|
1
|
Zeng Z, Zhu Z, Yang Y, Ruan W, Peng X, Su
Y, Peng L, Chen J, Yin Q, Zhao C, et al: Incidence and clinical
characteristics of inflammatory bowel disease in a developed region
of Guangdong Province, China: A prospective population-based study.
J Gastroenterol Hepatol. 28:1148–1153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sprong RC, Schonewille AJ and van der Meer
R: Dietary cheese whey protein protects rats against mild dextran
sulfate sodium-induced colitis: Role of mucin and microbiota. J
Dairy Sci. 93:1364–1371. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schirbel A and Fiocchi C: Inflammatory
bowel disease: Established and evolving considerations on its
etiopathogenesis and therapy. J Dig Dis. 11:266–276. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nagasaki A, Takahashi H, Iinuma M,
Uchiyama T, Watanabe S, Koide T, Tokoro C, Inamori M, Abe Y and
Nakajima A: Ulcerative colitis with multidrug-resistant Pseudomonas
aeruginosa infection successfully treated with bifidobacterium.
Digestion. 81:204–205. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang LS, Li YX, Zhu HM, Zhu ZS and Ma XD:
Influence of bifidobacterium DNA on PKC and NF-kappaB in murine
macrophages. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 23:11–13.
2007.(In Chinese). PubMed/NCBI
|
|
6
|
Servin AL: Antagonistic activities of
lactobacilli and bifidobacteria against microbial pathogens. FEMS
Microbiol Rev. 28:405–440. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Collado MC, Surono IS, Meriluoto J and
Salminen S: Potential probiotic characteristics of Lactobacillus
and Enterococcus strains isolated from traditional dadih fermented
milk against pathogen intestinal colonization. J Food Prot.
70:700–705. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Madsen KL: Inflammatory bowel disease:
Lessons from the IL-10 gene-deficient mouse. Clin Invest Med.
24:250–257. 2001.PubMed/NCBI
|
|
9
|
Mack DR, Ahrne S, Hyde L, Wei S and
Hollingsworth MA: Extracellular MUC3 mucin secretion follows
adherence of Lactobacillus strains to intestinal epithelial cells
in vitro. Gut. 52:827–833. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Frolova L, Drastich P, Rossmann P,
Klimesova K and Tlaskalova-Hogenova H: Expression of Toll-like
receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients
with inflammatory bowel diseases: Upregulated expression of TLR2 in
terminal ileum of patients with ulcerative colitis. J Histochem
Cytochem. 56:267–274. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu Y, Zhang Z, Wang L, Li J, Dong L, Yue
W, Chen J, Sun X, Zhong L and Sun D: TLR4 monoclonal antibody
blockade suppresses dextran-sulfate-sodium-induced colitis in mice.
J Gastroenterol Hepatol. 25:209–214. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fort MM, Mozaffarian A, Stöver AG, Jda S
Correia, Johnson DA, Crane RT, Ulevitch RJ, Persing DH,
Bielefeldt-Ohmann H, Probst P, et al: A synthetic TLR4 antagonist
has anti-inflammatory effects in two murine models of inflammatory
bowel disease. J Immunol. 174:6416–6423. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cooper HS, Murthy SN, Shah RS and
Sedergran DJ: Clinicopathologic study of dextran sulfate sodium
experimental murine colitis. Lab Invest. 69:238–249.
1993.PubMed/NCBI
|
|
14
|
Fromowitz FB, Viola MV, Chao S, Oravez S,
Mishriki Y, Finkel G, Grimson R and Lundy J: ras p21 expression in
the progression of breast cancer. Hum Pathol. 18:1268–1275. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Method. 25:402–408. 2001.
View Article : Google Scholar
|
|
16
|
Bullock NR, Booth JC and Gibson GR:
Comparative composition of bacteria in the human intestinal
microflora during remission and active ulcerative colitis. Curr
Issues Intest Microbiol. 5:59–64. 2004.PubMed/NCBI
|
|
17
|
Mardini HE and Grigorian AY: Probiotic mix
VSL#3 is effective adjunctive therapy for mild to moderately active
ulcerative colitis: A meta-analysis. Inflamm Bowel Dis.
20:1562–1567. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sang LX, Chang B, Dai C, Gao N, Liu WX and
Jiang M: Heat-killed VSL#3 ameliorates dextran sulfate sodium
(DSS)-induced acute experimental colitis in rats. Int J Mol Sci.
15:15–28. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang X, Fu Y, Liu J and Ren HY: Impact of
probiotics on toll-like receptor 4 expression in an experimental
model of ulcerative colitis. J Huazhong Univ Sci Technolog Med Sci.
33:661–665. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cario E: Toll-like receptors in
inflammatory bowel diseases: A decade later. Inflamm Bowel Dis.
16:1583–1597. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Østvik AE, Granlund AV, Torp SH, Flatberg
A, Beisvåg V, Waldum HL, Flo TH, Espevik T, Damås JK and Sandvik
AK: Expression of Toll-like receptor-3 is enhanced in active
inflammatory bowel disease and mediates the excessive release of
lipocalin 2. Clin Exp Immunol. 173:502–511. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Borrello S, Nicolo C, Delogu G, Pandolfi F
and Ria F: TLR2: A crossroads between infections and autoimmunity?
Int J Immunopathol Pharmacol. 24:549–556. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
D'Incà R, Barollo M, Scarpa M, Grillo AR,
Brun P, Vettorato MG, Castagliuolo I and Sturniolo GC: Rectal
administration of Lactobacillus casei DG modifies flora composition
and Toll-like receptor expression in colonic mucosa of patients
with mild ulcerative colitis. Dig Dis Sci. 56:1178–1187. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Roberts-Thomson IC, Fon J, Uylaki W,
Cummins AG and Barry S: Cells, cytokines and inflammatory bowel
disease: A clinical perspective. Expert Rev Gastroenterol Hepatol.
5:703–716. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Haller D, Russo MP, Sartor RB and Jobin C:
IKK beta and phosphatidylinositol 3-kinase/Akt participate in
non-pathogenic Gram-negative enteric bacteria-induced RelA
phosphorylation and NF-kappa B activation in both primary and
intestinal epithelial cell lines. J Biol Chem. 277:38168–38178.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Khor B, Gardet A and Xavier RJ: Genetics
and pathogenesis of inflammatory bowel disease. Nature.
474:307–317. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Van Deventer SJ: Tumour necrosis factor
and Crohn's disease. Gut. 40:443–448. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Suzuki M, Hisamatsu T and Podolsky DK:
Gamma interferon augments the intracellular pathway for
lipopolysaccharide (LPS) recognition in human intestinal epithelial
cells through coordinated up-regulation of LPS uptake and
expression of the intracellular Toll-like receptor 4-MD-2 complex.
Infect Immun. 71:3503–3511. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cantó E, Ricart E, Monfort D,
González-Juan D, Balanzó J, Rodríguez-Sánchez JL and Vidal S: TNF
alpha production to TLR2 ligands in active IBD patients. Clin
Immunol. 119:156–165. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rachmilewitz D, Karmeli F, Shteingart S,
Lee J, Takabayashi K and Raz E: Immunostimulatory oligonucleotides
inhibit colonic proinflammatory cytokine production in ulcerative
colitis. Inflamm Bowel Dis. 12:339–345. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hausmann M, Kiessling S, Mestermann S,
Webb G, Spöttl T, Andus T, Schölmerich J, Herfarth H, Ray K, Falk W
and Rogler G: Toll-like receptors 2 and 4 are up-regulated during
intestinal inflammation. Gastroenterology. 122:1987–2000. 2002.
View Article : Google Scholar : PubMed/NCBI
|
